CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...
Phase 3
Elwood, Indiana, United States and 125 other locations
28-week Phase 3 Efficacy and Safety Study of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent Asthma...
Phase 3
Bloomington, Indiana, United States and 121 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Elwood, Indiana, United States and 209 other locations
The goal of this clinical trial\] is to evaluate the long term safety of dexpramipexole treatment in participants with severe asthma, aged ≥...
Phase 3
Elwood, Indiana, United States and 5 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Indianapolis, Indiana, United States and 372 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Indianapolis, Indiana, United States and 362 other locations
MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis...
Phase 3
Indianapolis, Indiana, United States and 92 other locations
decline in adult patients with uncontrolled moderate to severe asthma.The estimated duration is 4±1 weeks of screening and run-in period, fo...
Phase 4
Indianapolis, Indiana, United States and 218 other locations
The purpose of the study is to evaluate effect of benralizumab on structural and lung function changes in severe eosinophilic asthmatics.Changes will...
Phase 4
Indianapolis, Indiana, United States and 52 other locations
This study will assess the efficacy and safety of daily OM-85 treatment compared to placebo in children aged 6 months to 5 years with recurrent wheez...
Phase 2
Indianapolis, Indiana, United States and 36 other locations
Clinical trials
Research sites
Resources
Legal